查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1970735

电脑刀市场－全球产业规模、份额、趋势、机会、预测：按应用、最终用途、地区和竞争格局划分，2021-2031年

CyberKnife Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球电脑刀市场预计将从 2025 年的 6.3855 亿美元成长到 2031 年的 17.2205 亿美元，复合年增长率达到 17.98%。

电脑刀系统是一种机器人立体定位放射放射线手术平台，能够以亚毫米级的精度将高能量辐射精准地输送到肿瘤部位，为传统手术提供了一种非侵入性的替代方案。人口老化和全球癌症负担日益加重是推动这一市场成长的主要因素，这些因素都迫切需要高效、以患者为中心的门诊治疗方案。根据美国癌症协会2024年的报告显示，美国新增癌症病例将首次超过200万例，凸显了对先进肿瘤治疗手段日益增长的迫切需求。

市场概览
预测期 2027-2031
市场规模：2025年 6.3855亿美元
市场规模：2031年 1,722,050,000 美元
复合年增长率：2026-2031年 17.98%
成长最快的细分市场 癌症
最大的市场 北美洲

然而，复杂的报销机制和严格的预先核准要求给医疗机构带来了沉重的行政负担，严重阻碍了放射外科技术的广泛应用。这些监管和财务障碍常常导致治疗延误或拒绝，限制了患者获得这项技术的机会。此外，由于行政流程的复杂性，小规模医疗机构往往难以证明投资收益率，因此在购买专业放射外科设备方面犹豫不决，不敢进行必要的巨额投资。

市场驱动因素

全球癌症和肿瘤疾病的日益普及是推动全球电脑刀市场发展的主要因素，也因此迫切需要精准、高通量的治疗方法。由于环境因素和人口老化导致发病率上升，医疗系统正优先部署能够以亚毫米级精度输送高剂量辐射的先进放射线手术平台。日益加重的疾病负担进一步凸显了对非侵入性治疗方法的需求，以有效应对复杂病例。世界卫生组织（WHO）于2024年2月发布题为《日益增长的全球癌症负担》的新闻稿指出，预计到2050年，全球新增癌症病例将超过3500万例，比2022年增长77%。这一趋势凸显了开发可扩展肿瘤解决方案的必要性，这些方案能够在不影响临床疗效的前提下，处理更多患者。

同时，由于患者对微创放射放射线手术的需求不断增长，市场也在扩张。与传统切除术相比，微创放射外科手术可显着缩短恢復时间和住院时间。患者积极寻求具有更佳组织保护能力的替代疗法，医院也因此被迫投资机器人辅助治疗系统，以保持竞争力并满足患者的这些偏好。这种转变体现在该领域的大规模资本投资。根据Accuray公司2024年8月发布的财务报告，该公司2024财年的总订单达到3.421亿美元，年增10%，这主要得益于系统部署量的增加。此外，该公司2024财年的年度净销售额达到4.466亿美元，显示该技术正持续广泛应用。

市场挑战

严格的预核准要求和复杂的报销机制是全球电脑刀市场扩张的重大障碍。这些行政障碍给医疗机构带来了沉重的营运负担，常常迫使他们将临床资源从治疗转移到处理保险核准。支付模式的不确定性和频繁的拒赔削弱了进行立体定位放射外科放射线手术所需的财务稳定性。因此，小规模的医疗机构，尤其是资金有限的机构，由于监管环境的不确定性，难以证明投资收益的合理性，因此对投资高成本的机器人平台犹豫不决。

这种就医延误的环境直接抑制了治疗数量和市场利用率。根据美国放射肿瘤学会 (ASTRO) 2024 年的一项调查，92% 的放射肿瘤科医生表示，由于预先核准要求，患者治疗被延误；约三分之一的医生指出，这些行政障碍导致患者放弃治疗。当患者因官僚效率低下而无法及时接受治疗时，对先进治疗方法的需求就会被人为抑制。患者数量的下降不仅会阻碍医疗机构的产生收入，还会为新采用者带来高风险，最终抑制整个市场的成长。

市场趋势

全球电脑刀市场正经历着向低分割和超低分割治疗的重大转变，这种疗法减少了治疗次数，并将治疗集中在高精度疗程中。临床医师正日益利用此系统亚毫米级的精准度，该系统可在1至5次分割内完成立体定位体外放射治疗（SBRT），从而提高患者的治疗效率和依从性。这一转变得到了强有力的临床证据支持，这些证据表明，对于前列腺癌等适应症，更短的治疗疗程安全有效。根据Accuray公司2024年10月发布的新闻稿，一项发表在《新英格兰医学日誌》上的研究显示，PACE-B试验表明，接受SBRT治疗的患者五年癌症控制率达到95.8%，仅需五天即可达到与传统长期治疗相当的疗效。

同时，相关人员正优先考虑建立策略伙伴关係，以拓展新兴经济体市场，尤其是在医疗现代化进程加速的亚太地区。製造商正努力应对复杂的监管环境，并发展本地合资企业，以满足中国等国家对先进放射治疗日益增长的需求。这种以本地市场为导向的策略使他们能够绕过进口壁垒，并为当地医院提供具有竞争力的价格。这种地域多元化策略的成功在近期的财务表现中得到了充分体现。根据Investing.com发布的2024年8月财报导，Accuray公司2024财年在中国的营收年增27%，这进一步证实了该地区在推动未来市场扩张方面发挥的关键作用。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球电脑刀市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依应用领域（肿瘤、癌症、血管畸形等）
    • 依最终用户（医院、门诊机构、研究机构、製造商）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美电脑刀市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲电脑刀市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区电脑刀市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲地区电脑刀市场的展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章： 电脑刀在南美洲的市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球电脑刀市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Accuray Incorporated
  • Varian Medical Systems Inc.
  • Koninklijke Philips NV
  • Hitachi, Ltd.
  • Mevion Medical Systems
  • Mitsubishi Heavy Industries, Ltd.
  • RaySearch Laboratories
  • Siemens Healthineers AG
  • ViewRay, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 23766

The Global CyberKnife Market is projected to expand from USD 638.55 Million in 2025 to USD 1722.05 Million by 2031, achieving a compound annual growth rate of 17.98%. Functioning as a robotic stereotactic radiosurgery platform, the CyberKnife System offers a non-invasive alternative to traditional surgery by delivering high-energy radiation to tumors with sub-millimeter precision. This market growth is primarily fueled by an aging population and the rising global burden of cancer, factors that necessitate efficient, patient-centric outpatient treatment solutions. As reported by the American Cancer Society in 2024, the number of new cancer diagnoses in the United States surpassed 2 million for the first time, highlighting the critical and escalating demand for advanced oncological interventions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 638.55 Million
Market Size 2031USD 1722.05 Million
CAGR 2026-203117.98%
Fastest Growing SegmentCancer
Largest MarketNorth America

However, widespread adoption is significantly hindered by complicated reimbursement structures and strict prior authorization mandates that impose heavy administrative workloads on healthcare providers. These regulatory and financial hurdles frequently lead to treatment delays or denials, restricting patient access to the technology. Furthermore, these barriers often discourage smaller medical facilities from committing to the substantial capital investment required for such specialized radiosurgery equipment, as the administrative complexities make the return on investment difficult to justify.

Market Driver

The escalating global prevalence of cancer and neoplastic diseases serves as the primary catalyst for the Global CyberKnife Market, creating an urgent need for precise, high-throughput treatment modalities. As incidence rates rise due to environmental factors and aging demographics, healthcare systems are prioritizing advanced radiosurgery platforms capable of delivering potent radiation doses with sub-millimeter accuracy. This increasing disease burden necessitates non-invasive options to manage complex cases efficiently. According to a February 2024 press release from the World Health Organization titled 'Global cancer burden growing,' more than 35 million new cancer cases are predicted for 2050, representing a 77% increase from 2022 levels, a trajectory that underscores the requirement for scalable oncological solutions that can handle higher patient volumes without compromising clinical outcomes.

Simultaneously, the market is expanding due to growing patient demand for minimally invasive radiosurgery, which offers significantly reduced recovery times and shorter hospital stays compared to traditional resection. Patients are actively seeking alternatives with superior tissue-sparing capabilities, compelling hospitals to invest in robotic delivery systems to maintain competitiveness and meet these preferences. This shift is reflected in substantial capital equipment investments within the sector. As noted by Accuray Incorporated in their August 2024 financial results, the company secured gross orders of $342.1 million for the fiscal year, a 10 percent increase driven by system placements. Additionally, the manufacturer's full-year net revenue reached $446.6 million in 2024, illustrating the sustained adoption of this technology.

Market Challenge

Stringent prior authorization requirements and complex reimbursement frameworks constitute a significant barrier to the expansion of the Global CyberKnife Market. These administrative obstacles place a heavy operational burden on healthcare providers, often forcing them to divert clinical resources toward managing insurance approvals rather than delivering care. The unpredictability of payment models and the frequency of claim denials undermine the financial stability required to offer specialized stereotactic radiosurgery. Consequently, medical facilities, particularly smaller centers with limited capital, are discouraged from investing in high-cost robotic platforms, as the return on investment becomes difficult to justify amidst such regulatory uncertainty.

This environment of delayed access directly suppresses procedure volumes and market utilization. According to the American Society for Radiation Oncology in 2024, 92% of radiation oncologists reported that prior authorization requirements caused treatment delays for their patients, with nearly one-third indicating that these administrative barriers led patients to abandon therapy entirely. When bureaucratic inefficiencies prevent patients from accessing timely treatment, the demand for advanced interventions is artificially curtailed. This reduction in patient throughput not only hampers revenue generation for providers but also signals a high-risk landscape for new adopters, effectively stalling broader market growth.

Market Trends

The Global CyberKnife Market is experiencing a decisive shift toward hypofractionated and ultra-hypofractionated regimens, condensing therapy into fewer, high-precision sessions. Clinicians are increasingly utilizing the system's sub-millimeter accuracy to deliver stereotactic body radiation therapy (SBRT) in one to five fractions, thereby improving patient throughput and treatment adherence. This transition is supported by strong clinical evidence validating the safety and efficacy of shortened schedules for indications such as prostate cancer. According to an Accuray Incorporated press release in October 2024 regarding a New England Journal of Medicine study, the PACE-B trial demonstrated that patients treated with SBRT achieved a 95.8 percent five-year cancer control rate, a result comparable to conventional longer regimens but delivered in just five days.

At the same time, stakeholders are prioritizing strategic partnerships to penetrate emerging economies, particularly in the Asia-Pacific region where healthcare modernization is accelerating. Manufacturers are establishing local joint ventures to navigate complex regulatory landscapes and meet the surging demand for advanced radiotherapy in countries like China. These localized strategies allow companies to bypass import barriers and price their systems competitively for regional hospitals. The success of this geographic diversification is evident in recent financial performances; according to an August 2024 Investing.com article on Accuray's earnings, the company reported that China revenue grew 27% year-over-year for fiscal 2024, underscoring the region's critical role in driving future market expansion.

Key Market Players

  • Accuray Incorporated
  • Varian Medical Systems Inc.
  • Koninklijke Philips N.V.
  • Hitachi, Ltd.
  • Mevion Medical Systems
  • Mitsubishi Heavy Industries, Ltd.
  • RaySearch Laboratories
  • Siemens Healthineers AG
  • ViewRay, Inc.

Report Scope

In this report, the Global CyberKnife Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

CyberKnife Market, By Application

  • Tumor
  • Cancer
  • Vascular malformation
  • Others

CyberKnife Market, By End-use

  • Hospitals
  • Outpatient facilities
  • Research
  • Manufacturing

CyberKnife Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global CyberKnife Market.

Available Customizations:

Global CyberKnife Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global CyberKnife Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Tumor, Cancer, Vascular malformation, Others)
    • 5.2.2. By End-use (Hospitals, Outpatient facilities, Research, Manufacturing)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America CyberKnife Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By End-use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States CyberKnife Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By End-use
    • 6.3.2. Canada CyberKnife Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By End-use
    • 6.3.3. Mexico CyberKnife Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By End-use

7. Europe CyberKnife Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By End-use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany CyberKnife Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By End-use
    • 7.3.2. France CyberKnife Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By End-use
    • 7.3.3. United Kingdom CyberKnife Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By End-use
    • 7.3.4. Italy CyberKnife Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By End-use
    • 7.3.5. Spain CyberKnife Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By End-use

8. Asia Pacific CyberKnife Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By End-use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China CyberKnife Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By End-use
    • 8.3.2. India CyberKnife Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By End-use
    • 8.3.3. Japan CyberKnife Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By End-use
    • 8.3.4. South Korea CyberKnife Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By End-use
    • 8.3.5. Australia CyberKnife Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By End-use

9. Middle East & Africa CyberKnife Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By End-use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia CyberKnife Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By End-use
    • 9.3.2. UAE CyberKnife Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By End-use
    • 9.3.3. South Africa CyberKnife Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By End-use

10. South America CyberKnife Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By End-use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil CyberKnife Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By End-use
    • 10.3.2. Colombia CyberKnife Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By End-use
    • 10.3.3. Argentina CyberKnife Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global CyberKnife Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Accuray Incorporated
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Varian Medical Systems Inc.
  • 15.3. Koninklijke Philips N.V.
  • 15.4. Hitachi, Ltd.
  • 15.5. Mevion Medical Systems
  • 15.6. Mitsubishi Heavy Industries, Ltd.
  • 15.7. RaySearch Laboratories
  • 15.8. Siemens Healthineers AG
  • 15.9. ViewRay, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer